Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
-
SoSe 2025
Vergangene Veranstaltungen (max. 10)
-
WiSe 2024
-
SoSe 2024
-
SoSe 2023
-
WiSe 2022
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Aldolase A : the broker of glycolysis: Cancer metabolismIn: Nature Metabolism 2025, Nr. 7, S. 242 – 244
-
Approaches to stable isotope tracing and in vivo metabolomics in the cancer clinicIn: The EMBO Journal 2025 , in pressDOI (Open Access)
-
Aspartate signalling drives lung metastasis via alternative translationIn: Nature , Jg. 638 2025, Nr. 2, S. 244 – 250
-
Changes in tumor and cardiac metabolism upon immune checkpointIn: Basic Research in Cardiology , Jg. 120 2025, Nr. 1, S. 133 – 152DOI (Open Access)
-
Deep imaging of LepR⁺ stromal cells in optically cleared murine bone hemisectionsIn: Bone Research , Jg. 13 2025, Nr. 1, 6DOI (Open Access)
-
High Glucose Contribution to the TCA Cycle Is a Feature of Aggressive Non-Small Cell Lung Cancer in PatientsIn: Cancer Discovery , Jg. 15 2025, Nr. 4, S. 702 – 716DOI (Open Access)
-
Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation statusIn: Frontiers in Immunology , Jg. 16 2025, 1536642DOI (Open Access)
-
Selenoprotein O Promotes Melanoma Metastasis and Regulates Mitochondrial Complex II ActivityIn: Cancer Research , Jg. 85 2025, Nr. 5, S. 942 – 955DOI (Open Access)
-
Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanomaIn: British Journal of Dermatology: BJD , Jg. 192 2025, Nr. 3, S. 481 – 491
-
Topical ruxolitinib for treatment-induced vitiligo in a patient with metastatic melanomaIn: JAAD Case Reports , Jg. 55 2025, S. 123 – 125DOI (Open Access)
-
Case report: : Durable complete response of a mucosal melanoma of the rectum after neoadjuvant immunotherapy with ipilimumab plus nivolumabIn: Frontiers in Immunology , Jg. 15 2024, 1369190DOI, Online Volltext (Open Access)
-
Comparison of visual diagnostic accuracy of dermatologists practicing in Germany in patients with light skin and skin of colorIn: Scientific Reports , Jg. 14 2024, Nr. 1, 8740DOI, Online Volltext (Open Access)
-
Cranioencephalic functional lymphoid units in glioblastomaIn: Nature Medicine , Jg. 30 2024, Nr. 10, S. 2947 – 2956DOI (Open Access)
-
De novo and salvage purine synthesis pathways across tissues and tumorsIn: Cell , Jg. 187 2024, Nr. 14, S. 3602 – 3618.e20
-
Diätetische Ansätze in der TumortherapieIn: TumorDiagnostik & Therapie , Jg. 45 2024, Nr. 3, S. 186 – 194
-
Early versus late response to PD-1-based immunotherapy in metastatic melanomaIn: European Journal of Cancer (EJC) , Jg. 210 2024, 114295DOI (Open Access)
-
Loss of Pip4k2c confers liver-metastatic organotropism through insulin-dependent PI3K-AKT pathway activationIn: Nature Cancer , Jg. 5 2024, Nr. 3, S. 433 – 447DOI (Open Access)
-
Multilokuläres Pyoderma gangraenosum durch Levamisol-gestrecktes KokainIn: Die Dermatologie , Jg. 75 2024, Nr. 8, S. 640
-
Pathogenic mitochondrial DNA mutations inhibit melanoma metastasisIn: Science Advances , Jg. 10 2024, Nr. 44, eadk8801DOI (Open Access)
-
Retrotransposons are co-opted to activate hematopoietic stem cells and erythropoiesisIn: Science , Jg. 386 2024, Nr. 6722, eado6836
-
Short-term post-fast refeeding enhances intestinal stemness via polyaminesIn: Nature , Jg. 633 2024, Nr. 8031, S. 895 – 904DOI (Open Access)
-
The Interplay between Metabolic Adaptations and Diet in Cancer ImmunotherapyIn: Clinical Cancer Research , Jg. 30 2024, Nr. 15, S. 3117 – 3127
-
Advancements in melanoma cancer metastasis modelsIn: Pigment Cell and Melanoma Research , Jg. 36 2023, Nr. 2, S. 206 – 223DOI (Open Access)
-
Characterisation and outcome of RAC1 mutated melanomaIn: European Journal of Cancer (EJC) , Jg. 183 2023, S. 1 – 10
-
Combined immunotherapy with ipilimumab plus nivolumab in metastatic PD-1/PD-L1-refractory Merkel cell carcinoma : a case reportIn: International Journal of Dermatology , Jg. 63 2023, Nr. 2, S. e69 – e71
-
Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma ADOREG/TRIM : Analysis of the DeCOG prospective multicenter cohort studyIn: eBioMedicine , Jg. 96 2023, 104774DOI (Open Access)
-
Diätetische Ansätze in der TumortherapieIn: Aktuelle Dermatologie , Jg. 49 2023, Nr. 12, S. 556 – 564
-
Ekzeme der Wundumgebung : Genese, Diagnostik und TherapieIn: Zeitschrift für Gerontologie und Geriatrie , Jg. 56 2023, Nr. 6, S. 505 – 515
-
Leptin receptor⁺ cells promote bone marrow innervation and regeneration by synthesizing nerve growth factorIn: Nature Cell Biology , Jg. 25 2023, Nr. 12, S. 1746 – 1757DOI (Open Access)
-
Multi-omics approaches to study platelet mechanismsIn: Current Opinion in Chemical Biology , Jg. 73 2023, 102253DOI (Open Access)
-
Multispectral optoacoustic tomography to differentiate between lymph node metastases and coronavirus-19 vaccine-associated lymphadenopathyIn: Journal of the European Academy of Dermatology and Venereology , Jg. 37 2023, Nr. 5: Special issue on melanoma: Immune check point and BRAF‐MEK inhibitors in melanoma, S. 907 – 913DOI (Open Access)
-
Prognostic factors in the primary care of patients with Merkel cell carcinoma : A monocentric cohort study of 108 patients from a tertiary referral centreIn: JEADV Clinical Practice , Jg. 2 2023, Nr. 4, S. 810 – 818DOI, Online Volltext (Open Access)
-
Compartmentalized metabolism supports midgestation mammalian developmentIn: Nature , Jg. 604 2022, Nr. 7905, S. 349 – 353DOI (Open Access)
-
Emerging metabolomic tools to study cancer metastasisIn: Trends in Cancer , Jg. 8 2022, Nr. 12, S. 988 – 1001DOI (Open Access)
-
In vivo isotope tracing reveals a requirement for the electron transport chain in glucose and glutamine metabolism by tumorsIn: Science Advances , Jg. 8 2022, Nr. 35, eabn9550DOI (Open Access)
-
Integrin alpha11 is an Osteolectin receptor and is required for the maintenance of adult skeletal bone massIn: eLife , Jg. 8 2022, S. e42274DOI (Open Access)
-
Loss of glucose 6-phosphate dehydrogenase function increases oxidative stress and glutaminolysis in metastasizing melanoma cellsIn: Proceedings of the National Academy of Sciences of the United States of America (PNAS) , Jg. 119 2022, Nr. 6, e2120617119DOI (Open Access)
-
Purine nucleotide depletion prompts cell migration by stimulating the serine synthesis pathwayIn: Nature Communications , Jg. 13 2022, Nr. 1, 2698DOI (Open Access)
-
A mechanosensitive peri-arteriolar niche for osteogenesis and lymphopoiesisIn: Nature , Jg. 591 2021, Nr. 7850, S. 438 – 444DOI (Open Access)
-
Isotope tracing reveals glycolysis and oxidative metabolism in childhood tumors of multiple histologiesIn: Med , Jg. 2 2021, Nr. 4, S. 395 – 410.e4DOI (Open Access)
-
Metabolomic profiling of rare cell populations isolated by flow cytometry from tissuesIn: eLife , Jg. 10 2021, e61980DOI (Open Access)
-
Redox regulation in cancer cells during metastasisIn: Cancer Discovery , Jg. 11 2021, Nr. 11, S. 2682 – 2692DOI (Open Access)
-
Stable isotope tracing to assess tumor metabolism in vivoIn: Nature Protocols , Jg. 16 2021, Nr. 11, S. 5123 – 5145DOI (Open Access)
-
The effect of parathyroid hormone on osteogenesis is mediated partly by osteolectinIn: Proceedings of the National Academy of Sciences of the United States of America (PNAS) , Jg. 118 2021, Nr. 25, e2026176118DOI (Open Access)
-
U-RT1 : A new model for Richter transformationIn: Neoplasia: An International Journal for Oncology Research , Jg. 23 2021, Nr. 1, S. 140 – 148DOI (Open Access)
-
Lymph protects metastasizing melanoma cells from ferroptosisIn: Nature , Jg. 585 2020, Nr. 7823, S. 113 – 118DOI (Open Access)
-
Metabolic heterogeneity confers differences in melanoma metastatic potentialIn: Nature , Jg. 577 2020, Nr. 7788, S. 115 – 120DOI (Open Access)
-
Mitochondrial DNA Haplotypes as Genetic Modifiers of CancerIn: Trends in Cancer , Jg. 6 2020, Nr. 12, S. 1044 – 1058
-
Loss of EZH2 reprograms BCAA metabolism to drive leukemic transformationIn: Cancer Discovery , Jg. 9 2019, Nr. 9, S. 1228 – 1247DOI (Open Access)
-
TRPML1 Promotes Protein Homeostasis in Melanoma Cells by Negatively Regulating MAPK and mTORC1 SignalingIn: Cell Reports , Jg. 28 2019, Nr. 9, S. 2293 – 2305.e9DOI (Open Access)
-
9-cis-Retinoic acid induces a distinct regulatory dendritic cell phenotype that modulates murine delayed-type allergyIn: Contact Dermatitis , Jg. 78 2018, Nr. 1, S. 41 – 54
-
NF-κB activation in astrocytes drives a stage-specific beneficial neuroimmunological response in ALSIn: The EMBO Journal , Jg. 37 2018, Nr. 16, e98697DOI (Open Access)
-
The H3K4 methyltransferase setd1b is essential for hematopoietic stem and progenitor cell homeostasis in miceIn: eLife , Jg. 7 2018, e27157DOI (Open Access)
-
Analysis of gender-specific Differences in Response to First-line Treatment with Immunotherapy or targeted Therapy in Melanoma Patients with metastatic Stage IV Melanoma : An ADO/DeCOG Study of 2032 Patients from the prospective, multicenter Skin Cancer Registry ADOREGIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 22 2024, Nr. Suppl. 4, S. 16 – 17
-
PD-L1 Expression in Lymph Node Metastases as a Predictor of adjuvant Immunotherapy Success in Stage III Melanoma Patients: An Analysis of the prospective ADOREG Study TRIM-ADJUVANTIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 22 2024, Nr. Suppl. 4, S. 15 – 16
-
The PD-L1 Expression predicts the Outcome of anti-PD-1/PD-L1-based Immune Checkpoint Therapy in Patients with metastatic Merkel Cell CarcinomaIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 22 2024, Nr. Suppl. 4, S. 17 – 18
-
Die PD-L1-Expression im Tumor prognostiziert je nach Art des untersuchten Gewebes das Outcome einer Anti-PD-1-basierten Immuntherapie bei metastasiertem Melanom
33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 27 – 28DOI (Open Access) -
Predictors of long-term survival of Stage IV melanoma patients: a multicenter DeCOG study on 395 patients from the prospective skin cancer registry ADOREG
52. Tagung der Deutschen Dermatologischen Gesellschaft, Vereinigung Deutschsprachiger Dermatologen e. V., 26.-29.04.2023, Berlin,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 21 2023, Nr. S1, Special Issue: Abstractband anlässlich der 52. Tagung der Deutschen Dermatologischen Gesellschaft, Vereinigung Deutschsprachiger Dermatologen e. V. 26. bis 29. April 2023, Berlin, S. 9 – 27DOI (Open Access) -
Predictors of long-term survival of stage IV melanoma patients : a multicenter DeCOG study on 539 patients from the prospective skin cancer registry ADOREG
32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 20 2022, Nr. S3, S. 16 – 17 -
Redirecting resistance evolution in BRAFV600 melanoma by inhibition of the peroxiredoxin-thioredoxin system2025DOI (Open Access)
-
Tumor PD-L1 predicts the outcome of PD-1-based immunotherapy in metastatic melanoma depending on the type of tissue examined
ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,In: Annals of Oncology , Jg. 34 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S695